PAMELA GILMORE: Open Payments
NPI 1922564194 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 35 payments from 17 companies in 2025. Trend: 2023 $735 · 2024 $629 · 2025 $1,149
Food & beverage: $1,050Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $145 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $127 |
| CVRx, Inc. | 1 | $114 |
| Ferring Pharmaceuticals Inc. | 5 | $109 |
| Sumitomo Pharma America, Inc. | 5 | $102 |
| ABBVIE INC. | 4 | $97 |
| 180 Medical, Inc. | 2 | $51 |
| Olympus America Inc. | 1 | $37 |
| Verity Pharmaceuticals Inc. | 2 | $31 |
Products named: ERLEADA, PYLARIFY, Kerendia, Barostim Neo System, ADSTILADRIN, BOTOX, GEMTESA, iTIND System.
Industry payments across SC — which companies pay providers there.
